CHALLENGER LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.65 AUD | -2.49% |
|
-1.34% | +2.47% |
| Sales 2024 * | 924M 593M | Sales 2025 * | 1.01B 647M | Capitalization | 4.56B 2.92B |
|---|---|---|---|---|---|
| Net income 2024 * | 328M 210M | Net income 2025 * | 441M 283M | EV / Sales 2024 * | 6.2 x |
| Net Debt 2024 * | 1.17B 751M | Net Debt 2025 * | 1.12B 717M | EV / Sales 2025 * | 5.62 x |
| P/E ratio 2024 * |
15.7
x | P/E ratio 2025 * |
11.7
x | Employees | 758 |
| Yield 2024 * |
3.87% | Yield 2025 * |
4.17% | Free-Float | 62.95% |
More Fundamentals
* Assessed data
More news
Latest transcript on Challenger Limited
More recommendations
More press releases
More news
| 1 day | -2.49% | ||
| 1 week | -1.34% | ||
| Current month | -6.47% | ||
| 3 months | +5.56% | ||
| 6 months | +7.78% | ||
| Current year | +2.47% |
1 week
6.41
7.03
1 month
6.417.17
Current year
6.217.29
1 year
5.677.29
3 years
4.777.83
5 years
2.8210.43
10 years
2.8214.42
| Managers | Title | Age | Since |
|---|---|---|---|
Nick Hamilton
CEO | Chief Executive Officer | - | 21-12-31 |
Alexandra Bell
DFI | Director of Finance/CFO | - | 22-11-30 |
Louise Roche
HRO | Human Resources Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
John Green
BRD | Director/Board Member | 71 | 17-12-05 |
| Director/Board Member | 59 | 17-12-05 | |
| Director/Board Member | 42 | Nov. 08 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.04% | 773 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 6.65 | -2.49% | 1,162,783 |
| 24-04-18 | 6.82 | +5.25% | 2,725,771 |
| 24-04-17 | 6.48 | -0.31% | 454,092 |
| 24-04-16 | 6.5 | -2.40% | 1,515,606 |
| 24-04-15 | 6.66 | -1.19% | 685,117 |
Delayed Quote Australian S.E., April 19, 2024 at 02:10 am EDT
More quotes
Challenger Limited is an Australia-based investment management company. The Company operates through two segments: Life and Funds Management. The Life segment principally includes the annuity and life insurance business carried out by Challenger Life Company (CLC). CLC offers fixed-rate and other retirement and superannuation products that are designed for Australian investors who are seeking a low-risk, fixed-term, or lifetime investment and reliable income. CLC also offers fixed-term and lifetime investments to investors in Japan through its reinsurance arrangement with Mitsui Sumitomo Primary Life Insurance Company Limited (MS Primary). CLC invests in assets that provide long-term income streams for customers. Its Funds Management segment is engaged in providing an end-to-end fund management business. The Funds Management segment also offers a range of managed investments across fixed income and property.
Sector
Life & Health Insurance
Calendar
2024-08-12
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
6.65
AUD
Average target price
7.537
AUD
Spread / Average Target
+13.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.47% | 2.93B | |
| -11.07% | 89.34B | |
| +16.91% | 73.83B | |
| -30.64% | 67.47B | |
| +2.02% | 28.45B | |
| +12.62% | 27.08B | |
| +0.31% | 26B | |
| +1.04% | 17.39B | |
| -6.98% | 15.52B | |
| +19.61% | 12.49B |
- Stock Market
- Equities
- CGF Stock
